Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $389.9M | $285.1M | $237.8M | $26.6M | $97M | |
| Gross Profit | $319.7M | $226M | $175.1M | $17.8M | $81.8M | |
| Operating Income | $269.9M | $200.2M | $245.3M | $70.9M | $52.5M | |
| EBITDA | $269.9M | $200.2M | $245.3M | $70.9M | $52.5M | |
| Diluted EPS | $1.37 | $0.69 | $1.14 | $0.32 | $0.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $193.6M | $77M | $107.4M | $85.7M | $140.7M | |
| Total Assets | $3.3B | $3.7B | $3.6B | $3.5B | $3.4B | |
| Current Liabilities | $76.6M | $68.8M | $79.1M | $77.9M | $85.7M | |
| Total Liabilities | $1.7B | $2.2B | $2B | $2B | $1.9B | |
| Total Equity | $1.6B | $1.5B | $1.6B | $1.6B | $1.5B | |
| Total Debt | $1.6B | $2.1B | $1.9B | $1.9B | $1.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $206.4M | $173.1M | $158.5M | $34.1M | $19.9M | |
| Cash From Investing | $148.6M | -$100.9M | $210.2M | $69.9M | $27.3M | |
| Cash From Financing | -$311.2M | -$95.9M | -$306.5M | -$112.8M | -$40.1M | |
| Free Cash Flow | $206.4M | $173.1M | $158.5M | $34.1M | $19.9M | |
Goldman Sachs BDC, Inc. invests in middle market companies located in the United States. The fund targets companies operating in the fields software, health technology information technology, commercial services and textiles with an investment size of $25 to $75 million and an EBITDA of $5 to $75 million. It provides financing in the form of senior secured debt, unitranche debt, junior secured, mezzanine debt and equity for acquisitions, refinancing, growth, LBOs, dividend recapitalization and restructuring transactions.
In the current month, GSBD has received 0 Buy ratings 4 Hold ratings, and 1 Sell ratings. The GSBD average analyst price target in the past 3 months is $10.31.
According to analysts, the consensus estimate is that Goldman Sachs BDC, Inc. share price will rise to $10.31 per share over the next 12 months.
Analysts are divided on their view about Goldman Sachs BDC, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Goldman Sachs BDC, Inc. is a Buy and believe this share price will drop from its current level to $12.00.
The price target for Goldman Sachs BDC, Inc. over the next 1-year time period is forecast to be $10.31 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Goldman Sachs BDC, Inc. is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
You can purchase shares of Goldman Sachs BDC, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Goldman Sachs BDC, Inc. shares.
Goldman Sachs BDC, Inc. was last trading at $9.19 per share. This represents the most recent stock quote for Goldman Sachs BDC, Inc.. Yesterday, Goldman Sachs BDC, Inc. closed at $9.31 per share.
In order to purchase Goldman Sachs BDC, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.